Bml Capital Management, LLC Elevation Oncology, Inc. Transaction History
Bml Capital Management, LLC
- $124 Billion
- Q1 2025
A detailed history of Bml Capital Management, LLC transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Bml Capital Management, LLC holds 5,890,934 shares of ELEV stock, worth $2.06 Million. This represents 1.24% of its overall portfolio holdings.
Number of Shares
5,890,934Holding current value
$2.06 Million% of portfolio
1.24%Shares
2 transactions
Others Institutions Holding ELEV
# of Institutions
72Shares Held
45.2MCall Options Held
100Put Options Held
3.3K-
Frazier Life Sciences Management, L.P. Menlo Park, CA5.99MShares$2.1 Million0.21% of portfolio
-
Tang Capital Management LLC San Diego, CA4.76MShares$1.67 Million0.21% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.53MShares$1.23 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA2.97MShares$1.04 Million0.06% of portfolio
-
Aisling Capital Management LP New York, NY2.83MShares$992,2180.6% of portfolio
About Elevation Oncology, Inc.
- Ticker ELEV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,300,900
- Market Cap $8.16M
- Description
- Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...